Attached files
| file | filename |
|---|---|
| EX-32.1 - LifeMD, Inc. | ex32-1.htm |
| EX-31.2 - LifeMD, Inc. | ex31-2.htm |
| EX-31.1 - LifeMD, Inc. | ex31-1.htm |
| EX-10.14 - LifeMD, Inc. | ex10-14.htm |
| EX-10.11 - LifeMD, Inc. | ex10-11.htm |
| EX-10.10 - LifeMD, Inc. | ex10-10.htm |
| EX-10.9 - LifeMD, Inc. | ex10-9.htm |
| EX-10.8 - LifeMD, Inc. | ex10-8.htm |
| 10-Q - LifeMD, Inc. | form10-q.htm |
Exhibit 32.2
LIFEMD, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
| Date: | August 13, 2021 | |
| By: | /s/ Marc Benathen | |
| Name: | Marc Benathen | |
| Title: | Chief Financial Officer (Principal Financial and Accounting Officer) |
|